Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by coalbet on Feb 20, 2021 3:11pm

Treatment!

The recent outbreak of COVID-19, which continues to ravage communities with high death tolls and untold psychosocial and catastrophic economic consequences, is a vivid reminder of nature's capacity to defy contemporary healthcare. The pandemic calls for rapid mobilization of every potential clinical tool, including phototherapy—one of the most effective treatments used to reduce the impact of the 1918 “Spanish influenza” pandemic. This paper cites several studies showing that phototherapy has immense potential to reduce the impact of coronavirus diseases, and offers suggested ways that the healthcare industry can integrate modern light technologies in the fight against COVID-19 and other infections. The evidence shows that violet/blue (400–470 nm) light is antimicrobial against numerous bacteria, and that it accounts for Niels Ryberg Finsen's Nobel-winning treatment of tuberculosis. Further evidence shows that blue light inactivates several viruses, including the common flu coronavirus, and that in experimental animals, red and near infrared light reduce respiratory disorders, similar to those complications associated with coronavirus infection. Moreover, in patients, red light has been shown to alleviate chronic obstructive lung disease and bronchial asthma. These findings call for urgent efforts to further explore the clinical value of light, and not wait for another pandemic to serve as a reminder. The ubiquity of inexpensive light emitting lasers and light emitting diodes (LEDs), makes it relatively easy to develop safe low-cost light-based devices with the potential to reduce infections, sanitize equipment, hospital facilities, emergency care vehicles, homes, and the general environment as pilot studies have shown.



Whereas some of the important lessons learned from past pandemics, such as social distancing, the use of facemasks and the search for new vaccines, have been marshalled to mitigate the pandemic, records indicate that, phototherapy, one of the most effective tools used to minimize the impact of the 1918 pandemic and other disease epidemics [] has been overlooked. This paper suggests that phototherapy, a seemingly forgotten treatment for bacterial and viral infections, has immense potential to reduce the impact of COVID-19 pandemic and similar coronavirus infections, particularly in view of recent developments in the field. Further, it reviews contemporary evidence for this assertion, and offers suggested ways that modern healthcare may integrate readily available inexpensive light technologies in its stash of clinical tools for patients with COVID-19 and other infections.
Comment by Pandora on Feb 20, 2021 4:59pm
"...records indicate that, phototherapy, one of the most effective tools used to minimize the impact of the 1918 pandemic and other disease epidemics [[7], [8], [9]] has been overlooked." Overlooked for over 100 years - gives one a lot of faith!
Comment by Jaro1977 on Feb 22, 2021 5:38pm
coalbet I replying here because I cannot reply on yoru Short post (the side bar covers the post button). can you please post the link to the page that shows the naked short position from in FINRA website. Thanks,
Comment by coalbet on Feb 22, 2021 6:21pm
https://shortdata.ca/largest-short-positions/
Comment by Jaro1977 on Feb 22, 2021 6:27pm
thanks
Comment by Pandora on Feb 22, 2021 8:23pm
Jaro, When you get a post like that and you find the "post" button is hidden from you if you scroll up a bit and on the right hand side in between two ads put the curser there and do a right click, that will bring up a menu, in the menu select 'Inspect element' and left click on it. That brings a bunch of programming text up at the bottom of the page. One wide column and two ...more  
Comment by Jaro1977 on Feb 22, 2021 8:29pm
Thanks Pandora.  I tried what you had suggest and I have no clue what I am looking at!  LOL, anyway, thanks for trying to help.  This problem only happens when the comment has image and the scroll bar to move the text box sideways.  Normally not a problem
Comment by Pandora on Feb 22, 2021 9:40pm
Jaro I will try once more and then leave it alone. If you are reading my post right now do you have an ad for "Deal Room" on the right side of the page? If so is there a 'space' below the ad and above the ad? If so can you move your curser into that space and do a 'right' click on it? When you do that do you get a pop up menu? If so do a regular 'left' click ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250